Lobe Sciences Ltd. (CSE:LOBE)
Canada · Delayed Price · Currency is CAD 0.0600
+0.0050 (9.09%)
At close: Feb 27, 2026
Lobe Sciences Market Cap
Lobe Sciences has a market cap or net worth of CAD 16.17 million as of March 2, 2026. Its market cap has increased by 371.24% in one year.
Market Cap
16.17M
Enterprise Value
11.64M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.06
Market Cap Chart
Since June 7, 2019, Lobe Sciences's market cap has decreased from 17.41M to 16.17M, a decrease of -7.14%. That is a compound annual growth rate of -1.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 16.17M | 33.33% |
| Dec 30, 2025 | 12.13M | 164.72% |
| Dec 31, 2024 | 4.58M | 131.55% |
| Dec 29, 2023 | 1.98M | -35.51% |
| Dec 30, 2022 | 3.07M | -54.48% |
| Dec 31, 2021 | 6.74M | -73.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Microbix Biosystems | 33.25M |
| Telescope Innovations | 28.69M |
| Thiogenesis Therapeutics | 27.99M |
| Rapid Dose Therapeutics | 20.28M |
| Quantum BioPharma | 18.60M |
| Hemostemix | 16.60M |
| Britannia Life Sciences | 16.23M |
| Innovotech | 13.52M |